Escalon Medical Corp. operates in the healthcare market. The Company is engaged in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. Its B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. Its UBM is a high frequency/high resolution ultrasound device, designed to provide information about the anterior segment of the eye. The Company's pachymeter measures the thickness of the cornea. Its color/fluorescein angiography digital imaging system is designed for ophthalmology. It distributes two intraocular gas products, C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery.
|Headquarters||435 Devon Park Dr Ste 100|
WAYNE, PA, United States 19087-1942
|Chairman of the Board||Richard DePiano|
|President, Chief Executive Officer, General Counsel, Director||Richard DePiano|
|Chief Financial Officer||Robert O'Connor|
|Chief Operating Officer||Mark Wallace|
|Director||C. Todd Trusk|
|Shares Out.||7.6M||Book Value||$0.25|
|Escalon Medical Corp does not pay a dividend.||P/E||--|
|P/Cash Flow (TTM)||--|
*GAAP = prior to non-GAAP analyst adjusted earnings.